Fred G Weiss is Director of RVL Pharmaceuticals plc. Currently has a direct ownership of 118,466 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on Aug 27, 2021, when has been sold 5,506 shares (Ordinary Shares) at a price of $3.31 per share, resulting in proceeds of $18,225. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0% 3M change
0% 12M change
Total Value Held $0

FRED G WEISS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 27 2021
SELL
Payment of exercise price or tax liability
$18,225 $3.31 p/Share
5,506 Reduced 4.44%
118,466 Ordinary Shares
Jul 02 2021
BUY
Grant, award, or other acquisition
-
61,188 Added 33.05%
123,972 Ordinary Shares
Jun 18 2021
SELL
Payment of exercise price or tax liability
$53,708 $2.89 p/Share
18,584 Reduced 22.84%
62,784 Ordinary Shares
Jan 24 2021
SELL
Payment of exercise price or tax liability
$24,552 $4.46 p/Share
5,505 Reduced 6.34%
81,368 Ordinary Shares
FGW

Fred G Weiss

Director
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP